What is the Number of Older Canadians Needed to Screen by Measurement of Bone Density to Detect an Undiagnosed Case of Osteoporosis? A Population-Based Study From CaMos

Journal of Clinical Densitometry

Volumn 9, Issue 4, 2006, Pages 413-418

  Sawka, Anna M ^a,b   Papaioannou, Alexandra ^c,d   Josse, Robert G ^a,e   Murray, Timothy M ^a,e   Ioannidis, George ^f   Hanley, David A ^g   Prior, Jerilynn C ^h   Thabane, Lehana ^c,i   Papadimitropoulos, E A ^j   Gafni, Amiram ^c,k   Pickard, Laura ^f   Anastassiades, Tassos ^l   Kirkland, Susan ^m   Adachi, Jonathan D ^c,f   the CaMos Research Group, ⁿ  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f Division of Rheumatology   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^j ELI LILLY AND COMPANY   (United States)

^k MCMASTER UNIVERSITY   (Canada)

^l QUEEN S UNIVERSITY   (Canada)

^m DALHOUSIE UNIVERSITY   (Canada)

ⁿ Canadian Multicentre Osteoporosis Study Research Group   (Canada)

more..

Author keywords

Bone density; mass screening; osteoporosis; prevalence

Indexed keywords

AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CANADA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING;

EID: 33750623889     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2006.07.004     Document Type: Article

References (37)

1. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
2. Watts N.B. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiomentry (DXA). Osteoporos Int 15 (2004) 847-854
3. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of the WHO study group. World Health Organ Tech Rep Ser 843 (1994) 1-129
4. Brown J.P., Josse R.G., and Scientific Advisory Council of the Osteoporosis Society of Canada. The 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 10 Suppl (2002) S1-S34
5. Brown J.P., Josse R.G., and Scientific Advisory Council of the Osteoporosis Society of Canada. Osteoporosis update: a practical guide for Canadian Physicians. Osteoporosis Update (Special Guidelines Issue) Winter 1 (2003) 1-19
6. Lewiecki E.M., Watts N.B., McClung M.R., Petak S.M., Bachrach L.K., Shepherd J.A., Downs Jr. R.W., and for the International Society for Clinical Densitometry. Official Positions of the International Society for Clinical Densitometry. J Clin Endo Metab 89 (2004) 3651-3655
7. The International Society for Clinical Densitometry. 2005 The ISCD Official Positions 2005. Website: http://www.iscd.org/Visitors/positions/OfficialPositionsText.cfm. Accessed April 2, 2006.
8. Cheung A.M., Feig D.S., Kapral M., Diaz-Granados N., Dodin S., and the Canadian Task Force on Preventative Health-Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventative Health Care. CMAJ 170 (2004) 1665-1667
9. Nelson H.D., Helfand M., Woolf S.H., and Allan J.D. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventative Services Task Force. Ann Intern Med 137 (2002) 529-541
10. US Preventative Services Task Force. 2002 Screening for Osteoporosis in postmenopausal women: recommendations and rationale. Agency for Healthcare research and Quality, Rockville, MD. Website: http://www/ahrq.gov/clinic/3rduspstf/osteoporosis/osteorr.htm. Accessed April 2, 2006.
11. National Osteoporosis Foundation. 2006 Osteoporosis: Bone Density. Website: http://www.nof.org/osteoporosis/bonemass.htm. Accessed April 2, 2006.
12. Siminoski K., Leslie W.D., Frame H., et al., for the Canadian Association of Radiologists. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56 (2005) 178-188
13. Cranney A., Guyatt G., Krolicki N., et al., the Osteoporosis Research Advisory Group. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporos Int 12 2 (2001) 140-151
14. Cranney A., Tugwell P., Zytaruk N., et al., the Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 23 4 (2002) 524-528
15. Cranney A., Tugwell P., Adachi J., et al., the Osteoporosis Methodology Group and the Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23 4 (2002) 517-523
16. Cranney A., Wells G., Willan A., et al., the Osteoporosis Methodology Group, and the Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23 4 (2002) 508-516
17. Cranney A., Guyatt G., Griffith L., Wells G., Tugwell P., Rosen C., Willan A., and the Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. IX. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23 4 (2002) 570-578
18. Guyatt G.H., Cranney A., Griffith L., Walter S., Krolicki N., Favus M., and Rosen C. Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol Metab Clin North Am 31 3 (2002) 659-679 xii
19. Papapoulos S.E., Quandt S.A., Liberman U.A., Hochberg M.C., and Thompson D.E. Meta-analysis of the efficacy of alendronate for the prevention of fractures in postmenopausal women. Osteoporos Int 16 (2005) 468-474
20. Nguyen N.D., Eisman J.A., and Nguyen T.V. Anti-hip fracture efficacy of bisphosphonates: Bayesian analysis of clinical trials. J Bone Miner Res 21 2 (2006) 340-349
21. Hodsman A.B., Bauer D.C., Dempster D.W., et al. Parathyroid hormone and teriperatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26 5 (2005) 688-703
22. Sawka A.M., Papaioannou A., Adachi J.D., Gafni A., Hanley D.A., and Thabane L. Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord 6 (2005) 39
23. Kreiger N., Tenenhouse A., Joseph L., et al. The Canadian Multicentre Osteoporosis Study (CaMos): Background, rationale, methods. Can J Aging 18 3 (1999) 376-387
24. Tenenhouse A., Joseph L., Kreiger N., et al., the CaMos Research Group. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: The Canadian Multicentre Osteoporosis Study. Osteoporos Int 11 (2000) 897-904
25. Genant H.K., Grampp S., Gluer C.C., et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9 10 (1994) 1503-1514
26. Altman D.G., Machin D., Bryant T.N., and Gardner M.J. Statistics with Confidence, 2nd ed (2000), British Medical Journal Publisher, London, UK 105-10
27. Statistics Canada. 2002 Profile of age and sex, for Canada, provinces, territories and federal electoral districts (1996 representation order), 2001 census. Website: =====http://www12.statcan.ca/english/census01/products/standard/profiles/RetrieveProfile.cfm?Temporal=2001&PID=56143&APATH=1&RL=2&IPS=95F0486XCB2001007. Accessed April 3, 2006.
28. Sawka A.M., Thabane L., Papaioannou A., et al., the CaMos Investigators. Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 16 12 (2005) 1836-1840
29. Kanis J.A., Johnell O., Oden A., et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int 17 4 (2006) 527-534
30. Johnell O., Kanis J.A., Oden A., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 20 7 (2005) 1185-1194
31. Delmas P.D., Rizzoli R., Cooper C., and Reginster J.Y. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 16 (2005) 1-5
32. Kanis J.A., Seeman E., Johnell O., Rizzoli R., and Delmas P. The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 16 (2005) 456-459
33. Sendi P., Al M.J., Gafni A., and Birch S. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med 57 (2003) 2207-2215
34. Kanis J.A., Johnell O., Oden A., De Laet C., Jonsson B., and Dawson A. Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30 1 (2002) 251-258
35. Kanis J.A., Johnell O., Oden A., Borgstrom F., Johansson H., De Laet C., and Jonsson B. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16 1 (2005) 6-14
36. Sanders K.M., Nicholson G.C., Watts J.J., Pasco J.A., Henry M.J., Kotowicz M.A., and Seeman E. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective?. Bone 38 5 (2006) 694-700
37. Kmetic A., Joseph L., Berger C., and Tenenhouse A. Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis. Epidemiology 13 4 (2002) 437-444